Ronald Boueri MD of Olympus Middle East and Africa and Colin Sheen, MD of Adcock Ingram Critical Care), signing the strategic partnership agreement.
Image: Supplied
Adcock Ingram Critical Care (AICC), a manufacturer and supplier of hospital and critical care products in Southern Africa, and Olympus, a global medical technology company that advances endoscopy-enabled care, aim to improve patient care through a strategic partnership.
The partnership will expand access to Olympus’ endoscopy solutions and broader medical and surgical technologies across the Southern African region, a statement said Tuesday.
Through the collaboration, AICC aims to support healthcare professionals with solutions and services for early detection, diagnosis, and minimally invasive treatment, while also strengthening access to clinical support, training, and education.
“We are equipping healthcare professionals with innovative solutions that support early detection, accurate diagnostics, and minimally invasive treatment, helping to enhance clinical outcomes and strengthen healthcare delivery across the region,” said Adcock Ingram Critical Care MD Colin Sheen in a statement.
He said Olympus has appointed Adcock Ingram Critical Care as its authorised distributor in South Africa.
“We are confident our collaboration with Adcock Ingram Critical Care in South Africa will enhance service levels, expand market reach, and ensure seamless access to Olympus products and expertise,” said Olympus’ Middle East and Africa vice president and managing director, Ronald Bouveri.
“This partnership will support healthcare professionals with the high standards of quality, service, and support they rely on, while contributing to improved patient outcomes and advancing healthcare across the country,” he added.
Adcock Ingram’s Critical Care portfolio already includes intravenous fluids, renal dialysis systems, products for the storage of blood and blood components, infusion systems and accessories, as well as a comprehensive range of ostomy and advanced wound care products. Adcock Ingram was delisted from the JSE last November following a successful takeover bid by India-based Natco Pharma, which saw it become a privately owned company jointly held with Bidvest
BUSINESS REPORT